Services

Press Release
Aug 26, 2019

Ypsomed starts production in Mecklenburg-Vorpommern

The Swiss diabetes specialist Ypsomed has started production at its new plant in Schwerin. The medtech company develops and manufactures injection and infusion systems for self-medication. In total, Ypsomed will invest more than 80 million euros in the Schwerin facility, where injection and infusion systems as well as infusion sets for insulin pumps will be produced. Around 150 new jobs are to be created in the medium term.

Over the last years, companies from Switzerland have created around 2,600 jobs in the federal state of Mecklenburg-Vorpommern, especially in the fields of medical technology, food, and metal processing.

Actions

Silke Poppe Silke Poppe | © GTAI

Contact Us

Silke Poppe

Director

‎+49 30 200 099-0

Geschäftsmann telefoniert mobil und schaut dabei auf sein Tablet | © iStock.com/mavoimages

Newsletter

Sign up for our free Eastern Germany Information Service to receive occasional news and event updates from one of Europe’s most dynamic economic regions.

Silke Poppe Silke Poppe | © GTAI

Contact Us

Silke Poppe

Director

‎+49 30 200 099-0